Vertex gets US regulator’s nod for extended use of cystic fibrosis drug
Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six
Danish pharmaceutical company Novo Nordisk’s combination drug achieved a 22.7% weight-loss reduction compared to a dummy drug during end-stage trials, according to a
The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia
HQ Team December 19, 2024: Recent studies have revealed a significant relationship between food allergies and atopic dermatitis (AD) in pediatric patients, indicating
Bharti Jayshankar December 19, 2024: The U.S. Food and Drug Administration (FDA) has issued a black box warning for Veozah, a medication designed
HQ Team December 18, 2024: Self-administered test for human papillomavirus, HPV, can help women self screen for risk of cervical cancer, according to
HQ Team December 18, 2025: Russia recently announced the development of a cancer vaccine, which is expected to be available for distribution free
Bharti Jayshankar December 17, 2024: The ICOD (Improving Condition in Down Syndrome) project has reported promising findings from its phase 1/2 clinical trial